Full Text Journal Articles by
Author Joren Callaert

Advertisement

Find full text journal articles








Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.

Alison Halliday, Richard Bulbulia, Leo H Bonati, Johanna Chester, Andrea Cradduck-Bamford, Richard Peto, Hongchao Pan, ,

<h4>Background</h4>Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or ... Read more >>

Lancet (Lancet (London, England))
[2021, 398(10305):1065-1073]

Cited: 1 time

View full text PDF listing >>



Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.

Marc Bosiers, Koen Deloose, Joren Callaert, Jürgen Verbist, Jeroen Hendriks, Patrick Lauwers, Herman Schroë, Wouter Lansink, Dierk Scheinert, Andrej Schmidt, Thomas Zeller, Ulrich Beschorner, Elias Noory, Giovanni Torsello, Martin Austermann, Jeroen Wauters,

<h4>Background</h4>This clinical trial aims to evaluate the outcome (up to 24-months) of the treatment of in-stent restenotic or reoccluded lesions in the femoropopliteal arteries, by comparing the treatment of the GORE<sup>®</sup> VIABAHN<sup>®</sup> Endoprosthesis with PROPATEN Bioactive Surface (W. L. Gore & Associates, Flagstaff, AZ, USA) with a standard PTA treatment. ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(5):617-625]

Cited: 1 time

View full text PDF listing >>



Advertisement

ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.

Marc Bosiers, Carlo Setacci, Gianmarco De Donato, Giovanni Torsello, Pierre Galvagni Silveira, Koen Deloose, Dierk Scheinert, Pierfrancesco Veroux, Jeroen Hendriks, Lieven Maene, Koen Keirse, Tulio Navarro, Joren Callaert, Hans-Henning Eckstein, Jörg Teβarek, Alessia Giaquinta, Jeroen Wauters,

Purpose: To report the 12-month results of a multicenter, prospective, randomized controlled trial to determine if the ZILVER PTX paclitaxel-eluting stent was noninferior in terms of safety and efficacy compared with surgical bypass. Materials and Methods: This is a study in symptomatic TransAtlantic Inter-Society Consensus (TASC) C and D femoropopliteal ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2020, 27(2):287-295]

Cited: 0 times

View full text PDF listing >>



One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.

Marc Bosiers, Koen Deloose, Giovanni Torsello, Dierk Scheinert, Jürgen Verbist, Wouter van den Eynde, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Hendriks, Joren Callaert, Michel Bosiers, Jeroen Wauters,

<h4>Background</h4>The aim of this study is to investigate the efficacy of the paclitaxel-eluting Legflow balloon catheter in the treatment of "real-world" long and complex femoropopliteal lesions.<h4>Methods</h4>The REFLOW study was a prospective, multi-national, non-randomized, single arm study evaluating the safety and efficacy of the Legflow paclitaxel-eluting balloon dilatation catheter in the ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(4):471-477]

Cited: 0 times

View full text PDF listing >>



One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients.

Kim Taeymans, Marc Bosiers, Koen Deloose, Joren Callaert, Koen Keirse, Jürgen Verbist, Wouter van den Eynde, Giovanni Torsello, Jeroen Wauters,

<h4>Background</h4>The aim of this study was to investigate the efficacy of the balloon expandable Promus Element and Promus Element Plus stents (both Boston Scientific, Marlborough, MA, USA), coated with everolimus, in the treatment of short, focal infrapopliteal lesions.<h4>Methods</h4>The PREVENT study was a prospective, multicenter, non-randomized, single arm study evaluating the ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(4):445-450]

Cited: 0 times

View full text PDF listing >>



Evaluation of a new dual-layer micromesh stent system for the carotid artery: 12-month results from the CLEAR-ROAD study.

Marc Bosiers, Koen Deloose, Giovanni Torsello, Dierk Scheinert, Lieven Maene, Patrick Peeters, Stefan Müller-Hülsbeck, Horst Sievert, Ralf Langhoff, Joren Callaert, Carlo Setacci, Jeroen Wauters,

EuroIntervention (EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology)
[2018, 14(10):1144-1146]

Cited: 1 time

View full text PDF listing >>



EVOLUTION Study: 12-month results.

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Jürgen Verbist, Wouter van den Eynde, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Wauters,

BACKGROUND:The EVOLUTION Study is a prospective, non-randomized study, investigating the iVolution stent (iVascular, Barcelona, Spain). The study was conducted at the vascular departments of four hospitals in Belgium. This manuscript reports the findings up to 12-month follow-up time for the total cohort. The primary endpoint of the study is primary ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2019, 60(4):490-495]

Cited: 1 time

View full text PDF listing >>



Less is more: the "As Less As Reasonably Achievable Stenting" (ALARAS) strategy in the femoropopliteal area.

Koen Deloose, Joren Callaert,

Although evidence supports that the performance of drug coated balloons seems to be lesion complexity independent, it is quite clear that in long lesions, severe calcified lesions and chronic total occlusions, the bail out stent ratio is very high and that the "leaving nothing behind" strategy remains a dream in ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2018, 59(4):495-503]

Cited: 0 times

View full text PDF listing >>



Endovascular treatment for the common femoral artery: is there a challenger to open surgery?

Koen Deloose, Igor Martins, Caio Neves, Joren Callaert,

Common femoral artery (CFA) atherosclerotic lesions currently remain one of the last limitations for adoption of endovascular repair as the first-line treatment. The bulky, eccentric, heavily calcified character of the CFA plaques, frequent involvement of the femoral bifurcation, easy surgical accessibility and last but not least, favorable long-term outcomes still ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2019, 60(1):8-13]

Cited: 1 time

View full text PDF listing >>



Anterograde or retrograde arterial access for diabetic limb revascularization.

Marc Bosiers, Koen Deloose, Joren Callaert,

The selection of an optimal vascular access strategy for lower limb endovascular intervention is key for procedural safety and success, and is particularly relevant in diabetic patients, in whom extensive occlusive disease commonly involves the infrapopliteal arteries. Individualizing vascular access requires careful planning, including determining normal and abnormal arterial anatomy; ... Read more >>

Semin Vasc Surg (Seminars in vascular surgery)
[2018, 31(2-4):76-80]

Cited: 1 time

View full text PDF listing >>



How to compare results from open with endovascular procedures?

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Jeroen Wauters,

BACKGROUND:According to the guidelines, bypass surgery is still the golden standard treatment in patients with femoropopliteal TASC C and D lesions and life-style limiting claudication or critical limb ischemia. Over the past few decades, endovascular therapy has made great advancements. However, the success rates of surgical and endovascular procedures cannot ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(2):196-199]

Cited: 0 times

View full text PDF listing >>



Impact of stent design on outcomes of carotid stent angioplasty.

Marc Bosiers, Koen Deloose, Joren Callaert, Jeroen Wauters,

Semin Vasc Surg (Seminars in vascular surgery)
[2018, 31(1):4-8]

Cited: 0 times

View full text PDF listing >>



AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.

Emily Benham, Koen Deloose, Joren Callaert, Marc Bosiers, Tiffany Cox, Amy Lincourt, B Todd Heniford,

Vascular closure devices (VCDs) are designed to achieve rapid hemostasis during percutaneous coronary and peripheral vascular procedures. Studies demonstrate that VCDs improve time to hemostasis (TTH) and time to ambulation (TTA) in comparison to standard manual compression. The available products, however, typically have 13-17 steps in their application, often require ... Read more >>

Surg Technol Int (Surgical technology international)
[2017, 31:93-99]

Cited: 0 times

View full text PDF listing >>



BeGraft Peripheral PMCF Study: 12-month results.

Koen Deloose, Marc Bosiers, Joren Callaert, Patrick Peeters, Jurgen Verbist, Wouter van den Eynde, Lieven Maene, Roel Beelen, Koen Keirse,

<h4>Background</h4>The BeGraft Peripheral PMCF study is a prospective, non-randomized study, conducted at the vascular departments of 4 hospitals in Belgium. This manuscript reports the findings up to 12-month follow-up time for the total cohort. The primary endpoint of the study is primary patency at 12 months. Primary patency is defined ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2019, 60(2):230-236]

Cited: 0 times

View full text PDF listing >>



Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care?

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Michel Bosiers,

Endovascular techniques have improved markedly over the past several decades. Plain old balloon angioplasty can only reach patencies around 40% after 1 year. Scaffolding stents have resulted in improved short-term results but encountered limitations for longer-term durability. With the introduction of drug-eluting technologies the process of intimal hyperplasia might be ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2016, 57(6):806-810]

Cited: 0 times

View full text PDF listing >>



One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.

Marc Bosiers, Joren Callaert, Koen Keirse, Jeroen M H Hendriks, Patrick Peeters, Jürgen Verbist, Lieven Maene, Roel Beelen, Koen Deloose,

<h4>Purpose</h4>To investigate the efficacy of the paclitaxel-coated, self-expanding, nitinol Stentys Stent System in tibioperoneal lesions ≤50 mm long.<h4>Methods</h4>The prospective, single-arm, multicenter PES-BTK-70 trial ( ClinicalTrials.gov identifier NCT01630070) evaluated the safety and efficacy of the coronary Stentys Stent System in the treatment of a stenotic or occlusive lesion ≤50 mm long ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2017, 24(3):311-316]

Cited: 3 times

View full text PDF listing >>



Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results.

Koen Deloose, Marc Bosiers, Joren Callaert, Jürgen Verbist, Frank Vermassen, Dierk Scheinert, Giovanni Torsello, Patrick Peeters,

The MISAGO ILIAC Study is a prospective, non-randomized, multicenter, bi-national, monitored trial, conducted in 3 hospitals in Belgium and 2 hospitals in Germany. This manuscript reports the findings up to 12-month follow-up time for the total cohort. The primary endpoint of the study was primary patency, defined as a target ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2017, 58(3):416-421]

Cited: 3 times

View full text PDF listing >>



Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.

Marc Bosiers, Koen Deloose, Joren Callaert, Jürgen Verbist, Jeroen Hendriks, Patrick Lauwers, Herman Schroë, Wouter Lansink, Dierk Scheinert, Andrej Schmidt, Thomas Zeller, Ulrich Beschorner, Elias Noory, Giovanni Torsello, Martin Austermann, Patrick Peeters,

<h4>Purpose</h4>To evaluate the short- and midterm outcomes of the Viabahn endoprosthesis with Propaten Bioactive Surface vs. standard balloon angioplasty for treatment of in-stent restenosis in the superficial femoral artery.<h4>Methods</h4>Between June 2010 and February 2012, 83 patients with superficial femoral artery in-stent and Rutherford category 2 to 5 ischemia were enrolled ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2015, 22(1):1-10]

Cited: 29 times

View full text PDF listing >>



4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.

Marc Bosiers, Koen Deloose, Joren Callaert, Koen Keirse, Jürgen Verbist, Jeroen Hendriks, Patrick Lauwers, Olivier D'Archambeau, Dierk Scheinert, Giovanni Torsello, Patrick Peeters,

<h4>Purpose</h4>To report the 1-year results of a prospective multicenter trial to evaluate the safety and efficacy of treating symptomatic femoropopliteal occlusive disease using 4-F-compatible materials and no closure device.<h4>Methods</h4>The non-randomized 4-EVER trial (4-F endovascular treatment approach to infrainguinal disease) was conducted at 5 European hospitals (ClinicalTrials.gov identifier NCT01413139). The protocol ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2013, 20(6):746-756]

Cited: 17 times

View full text PDF listing >>



Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.

Marc Bosiers, Koen Deloose, Joren Callaert, Nathalie Moreels, Koen Keirse, Jürgen Verbist, Patrick Peeters,

<h4>Objectives</h4>This study investigated the results with primary stenting using the Protégé EverFlex 200-mm-long self-expanding nitinol stent (ev3 Endovascular Inc, Plymouth, Minn) in femoropopliteal TransAtlantic Inter-Society Consensus (TASC) C and D lesions of at least 150 mm in length.<h4>Methods</h4>Between March 2008 and June 2009, 100 patients (66 men) presenting with 100 ... Read more >>

J Vasc Surg (Journal of vascular surgery)
[2011, 54(4):1042-1050]

Cited: 54 times

View full text PDF listing >>



Endoprosthetic treatment of a mycotic superficial femoral artery aneurysm.

Joren R G Callaert, Inge Fourneau, Kim Daenens, Geert Maleux, André Nevelsteen,

To describe the successful stent-graft exclusion of a mycotic aneurysm of the superficial femoral artery.A 78-year-old man presented with Salmonella arteritis and the formation of a mycotic false aneurysm of the superficial femoral artery. Antibiotics were administered; the aneurysm was excluded using 2 Hemobahn stent-grafts, and the surrounding hematoma was ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2003, 10(4):843-845]

Cited: 13 times

View full text PDF listing >>





Advertisement


Disclaimer

1.0419 s